Jazz Pharmaceuticals plc (JAZZ): Net Income
-$356.15M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$356.15M | n/m | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $560.12M | +35.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $414.83M | n/m | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | -$224.06M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$329.67M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $238.62M | -54.4% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $523.37M | +17.1% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $447.10M | -8.4% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $487.85M | +22.9% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $396.83M | +20.4% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $329.54M | +464.4% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $58.39M | -73.0% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $216.31M | -25.0% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $288.59M | +130.9% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $124.98M | +281.3% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $32.78M | n/m | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | -$6.84M | n/a | 2012-02-28, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$356.15M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.43B | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $313.75M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $286.93M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $348.90M | -18.3% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.33B | +11.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $72.06M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $187.00M | -78.4% |
Compare JAZZ, PRGO, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗